
Israel's parliament on Monday approved a controversial bill to reintroduce the death penalty for terrorists, a move considered racist by critics as the legislation would effectively only apply to Palestinians.
Rights organizations and several European countries had called for the initiative to be stopped.
Under the bill, Palestinians convicted of murder as an act of terrorism by military courts in the occupied territories would face a mandatory death sentence.
In civilian courts in Israel, meanwhile, a person convicted of murder with a terrorism motive with the aim of destroying the State of Israel could be sentenced either to death or to life imprisonment under the law.
The bill was introduced by the Otzma Yehudit party of far-right Minister of National Security Itamar Ben-Gvir.
A total of 62 of 120 lawmakers in the Knesset backed the bill in a final vote on Monday, including Prime Minister Benjamin Netanyahu. A total of 48 lawmakers voted against the bill, while the rest abstained or were not present for the vote.
latest_posts
- 1
Starbucks' new 'Bearista' cup is causing a stir — and is being listed on eBay for $600 - 2
Journey through Pages: A Survey of \Plunging into Scholarly Universes\ - 3
CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation - 4
Where America’s CO2 emissions come from – what you need to know, in charts - 5
Cruising Solo All over the Planet: An Excursion of Self-Disclosure
Astronomers may have spotted the 1st known 'superkilonova' double star explosion
David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
Fossil analysis changes what paleontologists know about how long T. rex took to grow full size
South African army arrive in crime hotspots to help tackle gangs
See the moon shine with Saturn in the southern sky after sunset Dec. 26
2024's Driving Clearing Robots: Master Suggestions and Surveys
Vote in favor of the juice that you love for its medical advantages!
The Most Famous Virtual Entertainment Powerhouses of the Year
US FDA declines to approve Corcept's drug for rare hormonal disorder












